- Home
- Publications
- Publication Search
- Publication Details
Title
NUTM1-rearranged Carcinoma of the Thyroid
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Volume Publish Ahead of Print, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-08-30
DOI
10.1097/pas.0000000000001967
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production
- (2022) Derek B. Allison et al. ENDOCRINE PATHOLOGY
- Primary Thyroid NUT Carcinoma With High PD-L1 Expression and Novel Massive IGKV Gene Fusions: A Case Report With Treatment Implications and Literature Review
- (2022) Juan Zhou et al. Frontiers in Oncology
- Report of the First International Symposium on NUT Carcinoma
- (2022) Christopher A. French et al. CLINICAL CANCER RESEARCH
- Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
- (2021) Jianfeng Li et al. Frontiers of Medicine
- Evaluation of Grade in a Genotyped Cohort of Sporadic Medullary Thyroid Carcinoma
- (2021) Fedaa Najdawi et al. HISTOPATHOLOGY
- Emerging entities in NUTM1 ‐rearranged neoplasms
- (2020) Christopher R. McEvoy et al. GENES CHROMOSOMES & CANCER
- A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma
- (2020) Geoffrey I. Shapiro et al. BRITISH JOURNAL OF CANCER
- NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum
- (2019) Todd M. Stevens et al. MODERN PATHOLOGY
- NUTM1 is a recurrent fusion gene partner in B cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2
- (2019) Femke M Hormann et al. HAEMATOLOGICA
- Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma
- (2019) Shigeki Sekine et al. JOURNAL OF CLINICAL INVESTIGATION
- NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors
- (2018) Brendan C. Dickson et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
- (2018) Nikita Pozdeyev et al. CLINICAL CANCER RESEARCH
- Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
- (2018) Jeremy Lewin et al. JOURNAL OF CLINICAL ONCOLOGY
- NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment
- (2018) Christopher A. French PATHOLOGY INTERNATIONAL
- Novel exon–exon breakpoint in CIC-DUX4 fusion sarcoma identified by anchored multiplex PCR (Archer FusionPlex Sarcoma Panel)
- (2017) Benjamin Nathanael Loke et al. JOURNAL OF CLINICAL PATHOLOGY
- Ectopic protein interactions within BRD4–chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma
- (2017) Artyom A. Alekseyenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma—an aggressive and fatal disease
- (2017) Anja Stirnweiss et al. Oncotarget
- Comparative molecular profiling of HPV-induced squamous cell carcinomas
- (2017) Robert F. Koncar et al. Cancer Medicine
- Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck
- (2016) Nicole G. Chau et al. CANCER
- Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
- (2016) Iñigo Landa et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
- (2016) A. Stathis et al. Cancer Discovery
- The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains
- (2015) Artyom A. Alekseyenko et al. GENES & DEVELOPMENT
- Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing
- (2015) John W. Kunstman et al. HUMAN MOLECULAR GENETICS
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations
- (2015) Lynette M. Sholl et al. Journal of Thoracic Oncology
- NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism
- (2014) C. A. French et al. Cancer Discovery
- MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma
- (2013) A R Grayson et al. ONCOGENE
- Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains
- (2010) Nicolas Reynoird et al. EMBO JOURNAL
- NUT Midline Carcinoma of the Parotid Gland With Mesenchymal Differentiation
- (2009) Michael A. den Bakker et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody
- (2009) Herbert Haack et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- NUT Midline Carcinoma in a Newborn with Multiorgan Disseminated Tumor and a 2-Year-Old with a Pancreatic/Hepatic Primary
- (2009) Bahig M. Shehata et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started